Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Off Episodes of Parkinson Disease”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Study completedNCT02542696
What this trial is testing

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Sumitomo Pharma America, Inc. 496
Large-scale testing (Phase 3)Study completedNCT02242487
What this trial is testing

Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 325
Post-approval studies (Phase 4)Study completedNCT00489255
What this trial is testing

Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment

Who this might be right for
Parkinson's Disease
Ipsen 117
Large-scale testing (Phase 3)Study completedNCT02352363
What this trial is testing

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 408
Large-scale testing (Phase 3)Study completedNCT00200512
What this trial is testing

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT01777555
What this trial is testing

Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 89
Large-scale testing (Phase 3)Study completedNCT02469090
What this trial is testing

Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease, Off Episodes
Sumitomo Pharma America, Inc. 141
Testing effectiveness (Phase 2)Study completedNCT03187301
What this trial is testing

A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes

Who this might be right for
Parkinson's DiseaseOff Episodes of Parkinson Disease
Sumitomo Pharma America, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07156773
What this trial is testing

The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes

Who this might be right for
Parkinson Disease
Guangzhou Novaken Pharm Co., Ltd. 84
Large-scale testing (Phase 3)Study completedNCT00142545
What this trial is testing

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 800
Large-scale testing (Phase 3)Study completedNCT02240030
What this trial is testing

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 351
Testing effectiveness (Phase 2)Study completedNCT03292016
What this trial is testing

A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes

Who this might be right for
Parkinson Disease
Sumitomo Pharma America, Inc. 8
Early research (Phase 1)Study completedNCT06037590
What this trial is testing

A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®

Who this might be right for
ParkinsonParkinson DiseaseParkinson's Disease and Parkinsonism
PureIMS B.V. 26
Not applicableStudy completedNCT05499572
What this trial is testing

Usability of Levodopa Cyclops™ vs INBRIJA® in Parkinson's Patients

Who this might be right for
Usability
Martini Hospital Groningen 16
Large-scale testing (Phase 3)Study completedNCT03391882
What this trial is testing

An Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Who this might be right for
Motor OFF Episodes Associated With Parkinson's Disease
Sumitomo Pharma America, Inc. 113
Large-scale testing (Phase 3)Study completedNCT00200525
What this trial is testing

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 60
Testing effectiveness (Phase 2)Ended earlyNCT05979415
What this trial is testing

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Who this might be right for
Parkinson Disease
Alexza Pharmaceuticals, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT01617135
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 25
Not applicableNot Yet RecruitingNCT07797790
What this trial is testing

Real-world Patient Experiences With Inbrija®

Who this might be right for
Parkinson Disease (PD)Parkinson's DiseaseOff Episodes of Parkinson Disease
Merz Therapeutics GmbH 120